vs
Side-by-side financial comparison of Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
Corbus Pharmaceuticals Holdings, Inc. is the larger business by last-quarter revenue ($1.2M vs $919.3K, roughly 1.3× Laser Photonics Corp). Laser Photonics Corp runs the higher net margin — -506.4% vs -1159.2%, a 652.8% gap on every dollar of revenue. On growth, Corbus Pharmaceuticals Holdings, Inc. posted the faster year-over-year revenue change (447.9% vs 28.3%).
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel targeted therapies for rare, serious inflammatory, fibrotic and immune-mediated diseases. It primarily operates across North America and other developed markets, addressing high unmet medical needs for underserved patient populations.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
CRBP vs LASE — Head-to-Head
Income Statement — Q3 FY2024 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $919.3K |
| Net Profit | $-13.8M | $-4.7M |
| Gross Margin | — | -20.1% |
| Operating Margin | -1304.0% | -350.0% |
| Net Margin | -1159.2% | -506.4% |
| Revenue YoY | 447.9% | 28.3% |
| Net Profit YoY | -37.1% | -186.5% |
| EPS (diluted) | $-1.15 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $919.3K | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $1.2M | $716.7K | ||
| Q2 24 | $906.0K | $623.4K | ||
| Q1 24 | $-177.0K | $743.0K | ||
| Q4 23 | — | $994.6K |
| Q3 25 | — | $-4.7M | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $586.4K | ||
| Q3 24 | $-13.8M | $-1.6M | ||
| Q2 24 | $-10.0M | $-934.3K | ||
| Q1 24 | $-6.9M | $-545.7K | ||
| Q4 23 | — | $-486.6K |
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% | ||
| Q4 23 | — | 84.5% |
| Q3 25 | — | -350.0% | ||
| Q2 25 | — | -37.0% | ||
| Q1 25 | — | -68.7% | ||
| Q4 24 | — | -255.1% | ||
| Q3 24 | -1304.0% | -238.0% | ||
| Q2 24 | -1212.8% | -149.4% | ||
| Q1 24 | 5436.3% | -73.8% | ||
| Q4 23 | — | -88.4% |
| Q3 25 | — | -506.4% | ||
| Q2 25 | — | -68.3% | ||
| Q1 25 | — | -73.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | -1159.2% | -226.8% | ||
| Q2 24 | -1103.4% | -149.9% | ||
| Q1 24 | 3897.4% | -73.4% | ||
| Q4 23 | — | -48.9% |
| Q3 25 | — | $-0.27 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-1.15 | $-0.13 | ||
| Q2 24 | $-0.90 | $-0.09 | ||
| Q1 24 | $-0.83 | $-0.06 | ||
| Q4 23 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.4M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $150.5M | $4.1M |
| Total Assets | $164.2M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $78.5K | ||
| Q1 25 | — | $179.1K | ||
| Q4 24 | — | $533.9K | ||
| Q3 24 | $159.4M | $2.1M | ||
| Q2 24 | $147.0M | $2.7M | ||
| Q1 24 | $120.1M | $5.2M | ||
| Q4 23 | — | $6.2M |
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $150.5M | $9.7M | ||
| Q2 24 | $125.5M | $10.3M | ||
| Q1 24 | $97.0M | $12.4M | ||
| Q4 23 | — | $13.9M |
| Q3 25 | — | $17.5M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $17.2M | ||
| Q3 24 | $164.2M | $10.6M | ||
| Q2 24 | $152.0M | $11.1M | ||
| Q1 24 | $125.7M | $13.6M | ||
| Q4 23 | — | $15.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.9M | $763.1K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $763.1K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-6.5M | ||
| Q3 24 | $-13.9M | $632.7K | ||
| Q2 24 | $-8.9M | $-2.4M | ||
| Q1 24 | $-8.0M | $-866.3K | ||
| Q4 23 | — | $-2.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-1.0M | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
